Lite Strategy, Inc. Dividends, Cash
Lite Strategy, Inc. (LITS) reported Dividends, Cash of $11.66 million for the 3-month period ending 2023-12-31, per its 10-Q filed 2024-05-09.
Discontinued › Shareholders' Equity
us-gaap:DividendsCash · last filed 2024-05-09
- Lite Strategy, Inc. dividends, cash for the quarter ending 2023-12-31 was $11.66M.
| Period end | Dividends, Cash 3 month |
|---|---|
| 2023-12-31 | $11.66M 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |